Abstract:Background and aimPrevious studies have reported an association between gut microbiota and cirrhosis. However, the causality between intestinal flora and liver cirrhosis still remains unclear. In this study, bi-directional Mendelian randomization (MR) analysis was used to ascertain the potential causal effect between gut microbes and cirrhosis.MethodsLarge-scale Genome Wide Association Study (GWAS) data of cirrhosis and gut microbes were obtained from FinnGen, Mibiogen consortium, and a GWAS meta-analysis of Alcoholic cirrhosis (ALC). Two-sample MR was performed to determine the causal relationship between gut microbiota and cirrhosis. Furthermore, a bi-directional MR analysis was employed to examine the direction of the causal relations.ResultIn MR analysis, we found that 21 gut microbiotas were potentially associated with cirrhosis. In reverse MR analysis, 11 gut microbiotas displayed potentially associations between genetic liability in the gut microbiome and cirrhosis. We found that the family Lachnospiraceae (OR: 1.59, 95% CI:1.10-2.29) might be harmful in cirrhotic conditions (ICD-10: K74). Furthermore, the genus Erysipelatoclostridium might be a protective factor for cirrhosis (OR:0.55, 95% CI:0.34-0.88) and PBC (OR:0.68, 95% CI:0.52-0.89). Combining the results from the MR analysis and reverse MR analysis, we firstly identified the Genus Butyricicoccus had a bi-directional causal effect on PBC (Forward: OR: 0.37, 95% CI:0.15-0.93; Reverse: OR: 1.03, 95% CI:1.00-1.05).ConclusionWe found a new potential causal effect between cirrhosis and intestinal flora and provided new insights into the role of gut microbiota in the pathological progression of liver cirrhosis. In this study, we employed Mendelian randomization method to investigate the causal correlation between gut microbiota and liver cirrhosis. We offered a novel perspective to explore the association between gut microbiota and the development of liver cirrhosis. Our findings revealed 21 specific gut microbiota that are significantly associated with the onset of cirrhosis, including the microbiota that have not been previously reported in literatures. Furthermore, our reverse analysis demonstrated that the state of liver cirrhosis influences the abundance of 11 distinct types of intestinal flora which have not been partly reported before.

Roles of Human Gut Microbiota in Liver Cirrhosis Risk: A Two-Sample Mendelian Randomization Study.

The causal relationship between gut microbiota and end-stage liver disease: a bidirectional Mendelian randomization analysis

Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses

The Causality Between Gut Microbiome and Liver Cirrhosis: a Bi-Directional Two-Sample Mendelian Randomization Analysis

Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis

Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis.

Association between gut microbiota and hepatocellular carcinoma and biliary tract cancer: A mendelian randomization study

Association of Gut Microbiome and Primary Liver Cancer: A Two‐sample Mendelian Randomization and Case–control Study

Association Between Gut Microbiota and NAFLD/NASH: a Bidirectional Two-Sample Mendelian Randomization Study

Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis

Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study

Characterization of the Gastric Mucosal Microbiota in Patients with Liver Cirrhosis and Its Associations with Gastrointestinal Symptoms

Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study

Causal relationships between the gut microbiota, inflammatory cytokines, and alcoholic liver disease: a Mendelian randomization analysis

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Relationship between gut microbiota and hepatocellular carcinoma through two-sample Mendelian randomization study

Causal associations between human gut microbiota and cholelithiasis: a mendelian randomization study

Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study

Alterations of the human gut microbiome in liver cirrhosis

Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals